INTT.AMEXIntest CORP

Form 4: InTEST Corp CFO Duncan Gilmour Reports Stock and Option Grants

Sentiment:

SEC Form 4 Filing


Duncan Gilmour, CFO, Treasurer, and Secretary of inTEST Corp, reports the acquisition of restricted stock and stock options.

Summary

  • On March 6, 2024, Duncan Gilmour, CFO, Treasurer, and Secretary of inTEST Corp, reported transactions involving inTEST CORP [INTT] common stock and employee stock options.
  • Gilmour acquired 7,356 restricted shares and 7,355 performance-based restricted shares at $0.
  • Following these transactions, Gilmour directly owns 46,401 common stock shares and indirectly owns 200 shares through a spouse.
  • Gilmour also acquired 12,724 employee stock options with an exercise price of $11.33, expiring on March 5, 2034.
  • Gilmour holds additional employee stock options with varying exercise prices and expiration dates.
  • The restricted shares and options were granted pursuant to the inTEST Corporation 2023 Stock Incentive Plan and are subject to vesting schedules.

Sentiment

Score: 6

Explanation: The document is a neutral regulatory filing. The grants are a standard part of executive compensation, and there are no indications of unusual or concerning activity.

Positives

  • The grant of restricted shares and stock options aligns the CFO's interests with the company's performance and shareholder value.
  • The vesting schedules encourage long-term commitment from the CFO.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting schedules of the granted shares and options.

Industry Context

This filing is a routine disclosure of insider transactions, common in publicly traded companies to ensure transparency and prevent insider trading. The grants are part of inTEST Corp's compensation strategy to incentivize its executives.

Comparison to Industry Standards

  • Stock option and restricted stock grants are a common form of executive compensation in the technology and manufacturing industries, used to align management's interests with those of shareholders.
  • Companies like Teradyne and Advantest also utilize similar equity-based compensation plans for their executives.
  • The vesting schedules and performance-based criteria are typical features designed to incentivize long-term performance and retention.

Stakeholder Impact

  • The grants could have a slightly dilutive effect on existing shareholders.
  • The grants incentivize the CFO to improve company performance, which benefits shareholders.

Key Dates

DateDescription
06/14/2022Commencement date for vesting of some existing employee stock options.
03/09/2023Commencement date for vesting of some existing employee stock options.
03/08/2024Vesting commencement date for some existing employee stock options.
03/06/2024Date of transaction: Grant of restricted shares and stock options.
03/06/2025Commencement date for vesting of new restricted shares and stock options.
03/06/2027Vesting date for performance-based restricted shares.
06/13/2031Expiration date for some existing employee stock options.
03/08/2032Expiration date for some existing employee stock options.
03/07/2033Expiration date for some existing employee stock options.
03/05/2034Expiration date for new employee stock options.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.